What is he best known for?
The fields of study he is best known for:
His primary areas of study are Plasmodium falciparum, Genetics, Malaria, Gene and Artemisinin.
His work carried out in the field of Plasmodium falciparum brings together such families of science as Genome-wide association study, Quinine, Molecular biology, Chloroquine and Drug resistance.
His Chloroquine research incorporates themes from Mutation and Apicomplexa.
Genetics is frequently linked to Genetic diversity in his study.
His Malaria research is multidisciplinary, incorporating elements of Genetic marker and Intensive care medicine.
His research integrates issues of Multiple drug resistance, Combination therapy, Pharmacology and Artesunate in his study of Artemisinin.
His most cited work include:
- Mutations in the P. falciparum Digestive Vacuole Transmembrane Protein PfCRT and Evidence for Their Role in Chloroquine Resistance (1148 citations)
- The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of plasmodium falciparum-infected erythrocytes (1021 citations)
- A molecular marker for chloroquine-resistant falciparum malaria. (828 citations)
What are the main themes of his work throughout his whole career to date?
Xin-zhuan Su mainly focuses on Genetics, Plasmodium falciparum, Malaria, Gene and Plasmodium yoelii.
Xin-zhuan Su is interested in Artemisinin, which is a branch of Plasmodium falciparum.
As a part of the same scientific study, Xin-zhuan Su usually deals with the Malaria, concentrating on Parasitology and frequently concerns with Multiple drug resistance.
His Gene research focuses on Molecular biology and how it relates to Recombinant DNA, Monoclonal antibody and Gene expression.
In Plasmodium yoelii, Xin-zhuan Su works on issues like Parasitemia, which are connected to Gametocyte.
His biological study spans a wide range of topics, including Mutation, Quinine and Apicomplexa.
He most often published in these fields:
- Genetics (59.91%)
- Plasmodium falciparum (56.31%)
- Malaria (38.29%)
What were the highlights of his more recent work (between 2014-2021)?
- Plasmodium yoelii (26.58%)
- Genetics (59.91%)
- Malaria (38.29%)
In recent papers he was focusing on the following fields of study:
Plasmodium yoelii, Genetics, Malaria, Gene and Plasmodium falciparum are his primary areas of study.
Xin-zhuan Su interconnects Interferon, Parasitemia, Immune system and Cell biology in the investigation of issues within Plasmodium yoelii.
His work in Genome, Plasmid, Single-nucleotide polymorphism, Genotype and Indel is related to Genetics.
The concepts of his Malaria study are interwoven with issues in Functional genomics, Computational biology, Disease and Microbiology.
His Plasmodium falciparum research is multidisciplinary, incorporating perspectives in Chloroquine, Genotyping, Parasitology and Drug resistance.
His Artemisinin study also includes fields such as
- Combination therapy, which have a strong connection to Genetic marker and Haplotype,
- Virology and related Heterophyes heterophyes.
Between 2014 and 2021, his most popular works were:
- Bone-Marrow-Resident NK Cells Prime Monocytes for Regulatory Function during Infection (136 citations)
- Indels, structural variation, and recombination drive genomic diversity in Plasmodium falciparum (97 citations)
- The discovery of artemisinin and the Nobel Prize in Physiology or Medicine (86 citations)
In his most recent research, the most cited papers focused on:
Xin-zhuan Su mostly deals with Plasmodium yoelii, Malaria, Immunology, Interferon and Artemisinin.
His Plasmodium yoelii research is multidisciplinary, relying on both Gene, CRISPR and Cell biology.
His Malaria research includes elements of Glutamine, Intracellular and Microbiology, Giardia lamblia.
His work deals with themes such as Progenitor cell and Cellular differentiation, which intersect with Immunology.
His Artemisinin research entails a greater understanding of Plasmodium falciparum.
His biological study deals with issues like Genetics, which deal with fields such as Resistance.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
